malignant pleural mesothelioma
Conditions
Interventions
None listed
Sponsors
Saitama Medical University International Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Pathological (histological or cytological) diagnosis of malignant pleural mesothelioma. 2.Patients whose stage of disease at diagnosis makes radical surgery or radical (chemo-)radiotherapy difficult or who have recurred after radical surgery or radical (chemo-)radiotherapy and who have been treated with cancer chemotherapy. 3.Initial drug therapy was initiated within the above time period. 4.Patients who have been fully informed of the enrollment in this study,and who have given written consent of their own free will based on sufficient understanding.
Exclusion criteria
Exclusion criteria: 1.Patients enrolled in prospective clinical trials (intervention studies) 2.Patients deemed inappropriate by the physician in charge for reasons such as inability to collect the information necessary to complete the Case Report Form (CRF).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| gender,age,PS/height,and weight at start of drug therapy regimen,Any history of asbestos exposure (if any, specific occupation) | — |
Secondary
| Measure | Time frame |
|---|---|
| Histological types (epithelial,sarcomatoid,biphasic,other),UICC TNM classification (III,I,Vpostoperative recurrence,recurrence after chemoradiotherapy),presence of pleural effusion,Blood test findings (neutrophil count,lymphocyte count,platelet count,serum albumin,CRP,LDH) | — |
Countries
Japan
Contacts
Public ContactImai Hisao
Saitama Medical University International Medical Center Respiratory Medicine
Outcome results
None listed